An exploratory study evaluating the 30 medications most commonly associated with headaches in the FDA Adverse Event Reporting System.

Source: Headache 2023 Jan 18; . doi: 10.1111/head.14453Authors: Musialowicz B, Kamitaki B, Zhang P

This project seeks to identify the top 30 drugs most commonly associated with headaches in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS), as well as their respective reporting odds ratios (RORs).

Pubmed ID: http://www.ncbi.nlm.nih.gov/pubmed/36651638?dopt=Abstract